Allergan PLC (AGN) on Wednesday reported a third-quarter loss of $4.03 billion, after reporting a profit in the same period a year earlier.
On a per-share basis, the Dublin-based company said it had a loss of $12.07. Earnings, adjusted for one-time gains and costs, came to $4.15 per share.
Continue Reading Below
The results topped Wall Street expectations. The average estimate of 19 analysts surveyed by Zacks Investment Research was for earnings of $4.06 per share.
The Botox maker posted revenue of $4.03 billion in the period, which matched Street forecasts.
Allergan expects full-year earnings in the range of $16.15 to $16.45 per share, with revenue in the range of $15.88 billion to $16.02 billion.
Allergan shares have dropped 16 percent since the beginning of the year, while the Standard & Poor's 500 index has risen 15 percent. The stock has fallen 15 percent in the last 12 months.
This story was generated by Automated Insights using data from Zacks Investment Research. Access a Zacks stock report on AGN at https://www.zacks.com/ap/AGN